Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

G7 to donate 1 billion COVID-19 vaccine doses to poorer countries

Thu, 10th Jun 2021 22:30

By Kate Holton

CARBIS BAY, England, June 10 (Reuters) - British Prime
Minister Boris Johnson expects the Group of Seven to agree to
donate 1 billion COVID-19 vaccine doses to poorer countries
during its summit starting on Friday, and help innoculate the
world by the end of next year.

Just hours after U.S. President Joe Biden vowed to
supercharge the battle against the coronavirus with a donation
of 500 million Pfizer shots, Johnson said Britain would
give at least 100 million surplus vaccines to the poorest
nations.

Johnson has already called on G7 leaders to commit to
vaccinate the entire world by the end of 2022 and the group is
expected to pledge 1 billion doses during its three-day summit
in the English seaside resort of Carbis Bay.

Some campaign groups condemned the plan as a drop in the
ocean, with Oxfam estimating that nearly 4 billion people will
depend on COVAX for vaccines, the programme that distributes
COVID-19 shots to low and middle income countries.

"As a result of the success of the UK's vaccine programme we
are now in a position to share some of our surplus doses with
those who need them," Johnson will say on Friday, according to
excerpts of the announcement released by his office.

"In doing so we will take a massive step towards beating
this pandemic for good."

COVID-19 has killed around 3.9 million people and ripped
through the global economy, with infections reported in more
than 210 countries and territories since the first cases were
identified in China in December 2019.

While scientists have brought vaccines to market at
breakneck speeds - Britain has given a first dose to 77% of its
adult population and the United States 64% - they say the
pandemic will only end once all countries have been vaccinated.

With a global population nearing 8 billion and most people
needing two doses, if not booster shots to tackle variants as
well, campaigners said the commitments marked a start but world
leaders needed to go much further, and much faster.

"The G7's aim to provide 1 billion doses should be seen as
an absolute minimum, and the timeframe needs to speed up," said
Lis Wallace at anti-poverty campaign group ONE.

"We're in a race with this virus and the longer it's in the
lead the greater the risk of new, more dangerous variants
undermining global progress."

Of the 100 million British shots, 80 million will go to the
COVAX programme led by the World Health Organization (WHO) and
the rest will be shared bilaterally with countries in need.

Johnson echoed Biden in calling on his fellow leaders to
make similar pledges and for pharmaceutical companies to adopt
the Oxford-AstraZeneca model of providing vaccines at cost for
the duration of the pandemic.

Leaving poorer countries to deal with the pandemic alone
risks allowing the virus to further mutate and evade vaccines.
Charities have also said that logistical support will be needed
to help administer large numbers of vaccines in poorer
countries.

The British doses will be drawn from the stock it has
already procured for its domestic programme, and will come from
suppliers Oxford-AstraZeneca, Pfizer-BioNTech,
Janssen, Moderna and others.

(Reporting by Kate Holton; editing by Guy Faulconbridge and
Grant McCool)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.